Direct answer: Elon Musk named Wegovy in an October 2022 reply about how he stayed fit. He later named Mounjaro in a December 2024 post clarifying his “Ozempic Santa” caption. The earlier article incorrectly said the 2022 reply was his entire public medication record. These are dated disclosures, not verification of his current prescription.
The original posts, with their context
| Record | What Musk named | What the post establishes |
|---|---|---|
| October 2022 reply to a question about fitness | Wegovy, following a separate reply mentioning fasting | He publicly attributed part of his approach at that time to that named product. |
| December 2024 clarification of a Santa photograph caption | Mounjaro | The product named in the clarification differs from the product used in the caption. |
The original Wegovy reply is linked below. X can display a different calendar date depending on the viewer's time zone; the article therefore identifies the month and year instead of treating a local timestamp as a universal date. The later clarification is also linked directly, rather than attributed to an unnamed report.
What these short statements do not establish
A product name supplies no dose, start date, stopping date, treatment duration or verified weight measurement. The earlier page estimated a 25-to-30-pound change from photographs and described its clinical pattern. That estimate is removed because an image comparison is not a measured outcome.
The earlier claim that Musk was the first major celebrity to disclose this treatment also lacked a defined comparison group or a complete historical record. A dated example can be documented without assigning it an unsupported place in a worldwide sequence.
Neither post tests the separate contributions of medication, food intake or activity. Linking a public statement to its author establishes attribution. It does not turn that person's experience into a controlled trial or a prediction for another reader.
FAQ: Questions about Musk's disclosures
Did he specifically name Wegovy?
Yes, in the linked October 2022 reply.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Did he later specifically name Mounjaro?
Yes, in the linked December 2024 clarification.
Do those posts establish what he uses today?
No. They document statements made at those dates, without confirming a present treatment.
Original sources
Footer disclaimers
Platform Disclaimer. FormBlends connects eligible patients with U.S.-licensed providers and pharmacies. We do not prescribe medication or dispense it. Independent providers determine clinical appropriateness in each case.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved products. They are prepared by a state-licensed 503A compounding pharmacy for an individual prescription. They have not been reviewed via the FDA new-drug pathway and should not be considered equivalent to brand-name Wegovy or Zepbound.
Results Disclaimer. Individual response varies. Reported clinical-trial averages (such as STEP 1's 14.9% mean weight loss) describe study populations and do not predict outcomes for individual patients. Elon Musk's reported outcome reflects his individual case, including reported fasting practice, and is not generalizable.
Trademark Notice. Wegovy and Ozempic are registered trademarks of Novo Nordisk. Tesla, SpaceX, and X are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Elon Musk, Novo Nordisk, Tesla, SpaceX, X, or any other party referenced in this article.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →